Time dependent modulation of tumor radiosensitivity by a pan HDAC inhibitor: abexinostat

Despite prominent role of radiotherapy in lung cancer management, there is an urgent need for strategies increasing therapeutic efficacy. Reversible epigenetic changes are promising targets for combination strategies using HDAC inhibitors (HDACi). Here we evaluated on two NSCLC cell lines, the antit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Rivera, Sofia, Leteur, Céline, Mégnin, Frédérique, Law, Frédéric, Martins, Isabelle, Kloos, Ioana, Depil, Stéphane, Modjtahedi, Nazanine, Perfettini, Jean Luc, Hennequin, Christophe, Deutsch, Eric
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5593556/
https://ncbi.nlm.nih.gov/pubmed/28915585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14813
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars